Immunomodulating Nanomedicine for Cancer Therapy

Zhigang Liu, Wen Jiang, Jutaek Nam, James J. Moon, Betty Y.S. Kim

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Nanomaterials offer unique advantages as drug-delivery vehicles for cancer therapeutics. For immuno-oncology applications, cancer nanomedicine should be developed beyond drug-delivery platforms. A greater emphasis on actively modulating host anticancer immunity using nanomaterials provides new avenues for developing novel cancer therapeutics.

Original languageEnglish (US)
Pages (from-to)6655-6659
Number of pages5
JournalNano Letters
Volume18
Issue number11
DOIs
StatePublished - Nov 14 2018

Fingerprint

Medical nanotechnology
Drug delivery
Nanostructured materials
therapy
cancer
Oncology
delivery
drugs
immunity
vehicles
platforms

Keywords

  • cancer immunotherapy
  • cancer vaccine
  • drug delivery
  • Nanomedicine
  • nanotechnology

ASJC Scopus subject areas

  • Bioengineering
  • Chemistry(all)
  • Materials Science(all)
  • Condensed Matter Physics
  • Mechanical Engineering

Cite this

Liu, Z., Jiang, W., Nam, J., Moon, J. J., & Kim, B. Y. S. (2018). Immunomodulating Nanomedicine for Cancer Therapy. Nano Letters, 18(11), 6655-6659. https://doi.org/10.1021/acs.nanolett.8b02340

Immunomodulating Nanomedicine for Cancer Therapy. / Liu, Zhigang; Jiang, Wen; Nam, Jutaek; Moon, James J.; Kim, Betty Y.S.

In: Nano Letters, Vol. 18, No. 11, 14.11.2018, p. 6655-6659.

Research output: Contribution to journalArticle

Liu, Z, Jiang, W, Nam, J, Moon, JJ & Kim, BYS 2018, 'Immunomodulating Nanomedicine for Cancer Therapy', Nano Letters, vol. 18, no. 11, pp. 6655-6659. https://doi.org/10.1021/acs.nanolett.8b02340
Liu, Zhigang ; Jiang, Wen ; Nam, Jutaek ; Moon, James J. ; Kim, Betty Y.S. / Immunomodulating Nanomedicine for Cancer Therapy. In: Nano Letters. 2018 ; Vol. 18, No. 11. pp. 6655-6659.
@article{74d4ae430db54d5e8600fcce9dedb489,
title = "Immunomodulating Nanomedicine for Cancer Therapy",
abstract = "Nanomaterials offer unique advantages as drug-delivery vehicles for cancer therapeutics. For immuno-oncology applications, cancer nanomedicine should be developed beyond drug-delivery platforms. A greater emphasis on actively modulating host anticancer immunity using nanomaterials provides new avenues for developing novel cancer therapeutics.",
keywords = "cancer immunotherapy, cancer vaccine, drug delivery, Nanomedicine, nanotechnology",
author = "Zhigang Liu and Wen Jiang and Jutaek Nam and Moon, {James J.} and Kim, {Betty Y.S.}",
year = "2018",
month = "11",
day = "14",
doi = "10.1021/acs.nanolett.8b02340",
language = "English (US)",
volume = "18",
pages = "6655--6659",
journal = "Nano Letters",
issn = "1530-6984",
publisher = "American Chemical Society",
number = "11",

}

TY - JOUR

T1 - Immunomodulating Nanomedicine for Cancer Therapy

AU - Liu, Zhigang

AU - Jiang, Wen

AU - Nam, Jutaek

AU - Moon, James J.

AU - Kim, Betty Y.S.

PY - 2018/11/14

Y1 - 2018/11/14

N2 - Nanomaterials offer unique advantages as drug-delivery vehicles for cancer therapeutics. For immuno-oncology applications, cancer nanomedicine should be developed beyond drug-delivery platforms. A greater emphasis on actively modulating host anticancer immunity using nanomaterials provides new avenues for developing novel cancer therapeutics.

AB - Nanomaterials offer unique advantages as drug-delivery vehicles for cancer therapeutics. For immuno-oncology applications, cancer nanomedicine should be developed beyond drug-delivery platforms. A greater emphasis on actively modulating host anticancer immunity using nanomaterials provides new avenues for developing novel cancer therapeutics.

KW - cancer immunotherapy

KW - cancer vaccine

KW - drug delivery

KW - Nanomedicine

KW - nanotechnology

UR - http://www.scopus.com/inward/record.url?scp=85053302027&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85053302027&partnerID=8YFLogxK

U2 - 10.1021/acs.nanolett.8b02340

DO - 10.1021/acs.nanolett.8b02340

M3 - Article

C2 - 30185039

AN - SCOPUS:85053302027

VL - 18

SP - 6655

EP - 6659

JO - Nano Letters

JF - Nano Letters

SN - 1530-6984

IS - 11

ER -